U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Global Insights And Revenue Growth Up To 2030
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Summary The U.S. prostate cancer nuclear medicine diagnostics market size was valued at USD 75.06 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. The increasing incidence of prostate cancer continues to be one of the major factors driving the demand for early and...
0 Kommentare 0 Anteile 112 Ansichten
Liện Hệ Quảng Cáo